Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
National HealthcareFRA:HTW -2.11%71 5-Year Yield-on-Cost % is 1.44 as of Aug. 15, 2026, which is 56% below its 10-year median of 3.28. GuruFocus rates FRA:HTW with a GF Score™ of 71/100 and a GF Value™ of €111.35. The stock has 5 warning signs investors should review. Among 276 Healthcare Providers & Services companies, National Healthcare ranks worse than 73.19% on this metric.
National Healthcare's yield on cost for the quarter that ended in Jun. 2026 was 1.44.
The historical rank and industry rank for National Healthcare's 5-Year Yield-on-Cost % or its related term are showing as below:
FRA:HTW'
s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 1.4 Med: 3.28 Max: 5.23
Current: 1.44
During the past 13 years, National Healthcare's highest Yield on Cost was 5.23. The lowest was 1.40. And the median was 3.28.
FRA:HTW's 5-Year Yield-on-Cost % is ranked worse than 73.19% of 276
companies
in the Healthcare Providers & Services industry
Industry Median: 2.91
vs FRA:HTW: 1.44
National Healthcare (FRA:HTW) 5-Year Yield-on-Cost % Explanation
Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.
National Healthcare 5-Year Yield-on-Cost % Related Terms
FRA:HTW vs BKD, OPCH, ACHC: 5-Year Yield-on-Cost % Comparison
For the Medical Care Facilities subindustry, National Healthcare's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
National Healthcare 5-Year Yield-on-Cost % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, National Healthcare's 5-Year Yield-on-Cost % distribution charts can be found below:
* The bar in red indicates where National Healthcare's 5-Year Yield-on-Cost % falls into.
National Healthcare 5-Year Yield-on-Cost % Calculation
Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.
Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.
National Healthcare (FRA:HTW) has a 5-Year Yield-on-Cost % of 1.44 as of Aug. 15, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on National Healthcare and its competitors. This is 56% below median its historical median of 3.28. Over the past decade, National Healthcare's 5-Year Yield-on-Cost % has ranged from 1.40 to 5.23. According to the industry distribution chart, National Healthcare ranks #202 out of 276 companies in the Healthcare Providers & Services industry, placing it in the top 73.2%.
Is National Healthcare's 5-Year Yield-on-Cost % too high?
National Healthcare's current 5-Year Yield-on-Cost % of 1.44 is 56% below median its 10-year median of 3.28. Over the past 10 years, this metric has ranged from a low of 1.40 to a high of 5.23. The Healthcare Providers & Services industry median 5-Year Yield-on-Cost % is 2.91. National Healthcare's value of 1.44 is 50.5% below this industry median. Based on the distribution chart, National Healthcare ranks #202 out of 276 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, National Healthcare has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does National Healthcare's 5-Year Yield-on-Cost % compare to BKD and OPCH?
According to the Healthcare Providers & Services industry distribution chart, National Healthcare ranks #202 out of 276 companies for 5-Year Yield-on-Cost %. This places National Healthcare in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.91. National Healthcare's value of 1.44 is 50.5% below this benchmark. Historically, National Healthcare's own 5-Year Yield-on-Cost % has ranged from 1.40 to 5.23 over the past decade. While the company's 10-year median is 3.28 vs. the industry median of 2.91, National Healthcare has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Healthcare Providers & Services company?
The median 5-Year Yield-on-Cost % among Healthcare Providers & Services companies is 2.91, based on 276 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. National Healthcare's current 5-Year Yield-on-Cost % of 1.44 is 50.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on National Healthcare and its competitors. For the Healthcare Providers & Services industry, the median 5-Year Yield-on-Cost % is 2.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. National Healthcare's current 5-Year Yield-on-Cost % is 1.44, which is 56% below median its own 10-year median of 3.28. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is National Healthcare stock overvalued right now?
National Healthcare (FRA:HTW) has a current 5-Year Yield-on-Cost % of 1.44. The stock's GF Value™ is €111.35, compared to a current price of €186.00 — trading 67% above its estimated fair value. The current 5-Year Yield-on-Cost % is 1.44, which is 56% below median its 10-year median of 3.28 and 50.5% below the Healthcare Providers & Services industry median of 2.91. National Healthcare's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For National Healthcare (FRA:HTW), the current 5-Year Yield-on-Cost % is 1.44 as of Aug. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is National Healthcare (FRA:HTW) Overvalued in 2026?
Based on GuruFocus' analysis, National Healthcare stock appears to be overvalued.
The current stock price of €186.00 is trading 67% above its estimated GF Value™ of €111.35.
Key valuation signals for FRA:HTW:
5-Year Yield-on-Cost %: 1.44 (56% below median its 10-year median of 3.28)
GF Value™: €111.35 vs. price of €186.00 (67% above fair value)
Industry Position: 50.5% below the Healthcare Providers & Services median (#202 of 276)
No single metric tells the full story. See the FRA:HTW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
National Healthcare Corp provides long-term care facilities. Its principal business includes operating skilled nursing facilities, assisted living facilities, independent living facilities, and home care programs. The company's activities include providing sub-acute and post-acute skilled nursing care, intermediate nursing care, rehabilitative care, memory and Alzheimer's care, senior living services, and home health care services. In addition, the company also provides management services, accounting, and financial services, as well as insurance services to third-party operators of healthcare facilities. Its reportable segments include Inpatient services and Home care and hospice services. The majority of revenue is derived from the Inpatient services segment.
71GF Score
Get the complete analysis for FRA:HTW
5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:HTW has been successfully added to your 
